trending Market Intelligence /marketintelligence/en/news-insights/trending/wmD6Wohxhp8X6C3P7lakyA2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

AMS Life Science fiscal Q2 profit climbs 5.7% YOY

Blog

COVID-19 Impact & Recovery: LCD Outlook for H2 2021

Blog

COVID 19 Impact Recovery Media Telecom and Technology Outlook for H2 2021

Blog

COVID-19 Impact & Recovery: Technology Outlook for H2 2021

Blog

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


AMS Life Science fiscal Q2 profit climbs 5.7% YOY

AFC-HD AMS Life Science Co. Ltd. said its normalized net income for the fiscal second quarter ended Feb. 29 amounted to ¥8.96 per share, an increase of 6.9% from ¥8.38 per share in the prior-year period.

Normalized net income, which excludes unusual gains or losses on a pre- and after-tax basis, was ¥108.8 million, an increase of 5.7% from ¥102.9 million in the prior-year period.

The normalized profit margin increased to 3.0% from 3.0% in the year-earlier period.

Total revenue rose year over year to ¥3.57 billion from ¥3.41 billion, and total operating expenses increased from the prior-year period to ¥3.38 billion from ¥3.23 billion.

Reported net income increased on an annual basis to ¥118.4 million, or ¥9.75 per share, from ¥114.2 million, or ¥9.30 per share.

As of April 14, US$1 was equivalent to ¥109.17.